Robotic Surgery Orlando Florida

Kidney cancer now accounts for approximately 40,000 new cases in the United States every year.  It is also responsible for 13,000 deaths annually making it the most lethal of all urological malignancies.  Small renal masses (SRMs) account for about 70% of all new cases of kidney cancer.  The incidence of these small renal masses has increased over the past 20 years due to the increase of imaging being performed including CAT scans and kidney ultrasounds. 

The primary treatment of kidney cancer remains surgical in nature, which provides the best chance for cure.  Options for treatment include open radical kidney removal or nephrectomy, laparoscopic nephrectomy, ablative techniques (cryotherapy, radiofreqency), and partial removal of the kidney.  Partial kidney removal is particularly important for those SRMs that are being diagnosed with more regularity.  The goal is to preserve as much kidney function as possible to maintain and preserve an excellent quality of life.

Presently the da Vinci robotic system provides the unique opportunity to maximize a surgeons ability to preserve and protect as much kidney tissue as possible.  This correlates to a decrease in chronic kidney diseases, and co morbid illnesses  such as cardiac events and hospitalization rates.  Most importantly partial removal of the kidney for cancer provides the patient with excellent oncological outcomes comparable to open surgery and removal of the entire kidney.

Dr. McDonald, has performed over 450 laparoscopic and robotic kidney surgeries and reviews each patients overall health, stage of cancer, and surgical risks to determine the best treatment available.   He is determined to provide excellent patient care in the surgical setting to promote the best oncological outcomes and maximize the patients return to their normal functioning status before surgery.